Concepedia

Publication | Closed Access

Pharmacokinetics of the Cardioprotector ADR-529 (ICRF-187) in Escalating Doses Combined With Fixed-Dose Doxorubicin

DOI

78

Citations

0

References

1992

Year

Howard S. Höchster, Leonard Liebes, Scott Wadler, Ruth Oratz, J Wernz, Michael L. Meyers, Michael D. Green, Ronald H. Blum, James L. Speyer
JNCI Journal of the National Cancer Institute

Abstract

We recommend that an ADR-529 dose of 600 mg/m2 be given with single-agent doxorubicin at a dose of 60 mg/m2 in future studies.